Vanguard disaggregation: Eli Lilly (NYSE: LLY) ownership shows 0 shares
Rhea-AI Filing Summary
Eli Lilly & Co — Schedule 13G/A amendment: The Vanguard Group reports 0 shares beneficially owned of Eli Lilly common stock, representing 0% of the class, following an internal realignment effective January 12, 2026. The filing states certain Vanguard subsidiaries will report holdings separately in reliance on SEC Release No. 34-39538.
Positive
- None.
Negative
- None.
Insights
Vanguard disaggregated holdings; this amendment shows no reported beneficial ownership in LLY.
The filing records 0 shares and 0% ownership and explains an internal realignment on January 12, 2026 that caused subsidiaries to report separately in reliance on SEC Release No. 34-39538. This is an administrative disclosure describing reporting structure rather than a trading event.
Cash‑flow treatment or subsidiary-level share counts are not provided in this excerpt; subsequent filings by Vanguard subsidiaries may show holdings under their own names.